Roscovitine blocks leukocyte extravasation by inhibition of cyclin‐dependent kinases 5 and 9

Abstract

Our study highlights a novel mode of action for roscovitine, preventing endothelial activation and leukocyte-endothelial cell interaction by inhibition of CDK5 and 9. This might expand its usage as a promising anti-inflammatory compound.